GreenLight Biosciences
Medford, US · Delaware corporation · 7 known investors
GreenLight Biosciences develops RNA-based solutions for agriculture and pest control, including a Colorado potato beetle bio-insecticide and a Varroa destructor mite-control product for sustainable food production.
Founders & leadership
AZ
Andrey ZarurExecutive Officer, Director
CL
Charles L. CooneyDirector
DF
David FurneauxDirector
MO
Marta Ortega-ValleExecutive Officer
WB
William BlakeExecutive Officer
JF
Jonathan FlemingDirector
JS
James SwartzDirector
NR
Neil RenningerDirector
GK
Ganesh KishoreDirector
Investors · 7
Reported raises · per SEC filings
Form D private placements▶$102.5MraisedJun 2020 · 19 investors · Other TechnologyRule 506(b)
▶$102.5MraisedJun 2020 · 19 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Martha SchlicherDirector
- Ganesh KishoreDirector
- Charles CooneyDirector
- Andrey ZarurExecutive Officer, Director
- Michael LiangDirector
- Matthew WalkerDirector
- Jason DingesDirector
- Eric O'BrienDirector
- Offering amount
- $110M
- Amount sold
- $102.5M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.7MraisedDec 2018 · 15 investors · Other TechnologyRule 506(b)
▶$38.7MraisedDec 2018 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew WalkerDirector
- Charles CooneyDirector
- Neil RenningerDirector
- David FurneauxDirector
- Martha SchlicherDirector
- Ganesh KishoreDirector
- Eric O'BrienDirector
- Andrey ZarurExecutive Officer, Director
- Offering amount
- $53.3M
- Amount sold
- $38.7M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedSep 2017 · 10 investors · Other TechnologyRule 506(b)
▶$10MraisedSep 2017 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles CooneyDirector
- Neil RenningerDirector
- James SwartzDirector
- Eric O'BrienDirector
- Ganesh KishoreDirector
- Jonathan FlemingDirector
- Andrey ZarurExecutive Officer, Director
- Marta Ortega-ValleExecutive Officer
- David FurneauxDirector
- Offering amount
- $18M
- Amount sold
- $10M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedJun 2015 · 7 investors · BiotechnologyRule 506(b)
▶$20MraisedJun 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrey ZarurExecutive Officer, Director
- Charles L. CooneyDirector
- David FurneauxDirector
- Marta Ortega-ValleExecutive Officer
- William BlakeExecutive Officer
- Jonathan FlemingDirector
- James SwartzDirector
- Neil RenningerDirector
- Ganesh KishoreDirector
- Offering amount
- $20M
- Amount sold
- $20M
- Minimum investment
- $91K
- Proceeds to insiders
- $675K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- GreenLight Biosciences raises $102M to bring sustainable biopesticides and a COVID-19 vaccine to marketagreads.com · 2020
- GreenLight Biosciences supercharges its efforts with $102M Series D funding from top-tier investors including Morningside Ventures, S2G Ventures and Lupa Systemsprnewswire.com · 2020
- GreenLight Raises $17M for COVID-19 Vaccine Production | Baird Capitalbairdcapital.com · 2020
- GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccinesprnewswire.com · 2020
- First Flight Venture Center — GreenLight Biosciences: Raises $50 million in funding in 2019ffvcnc.org · 2019